Armor Investment Advisors’s Pfizer PFE Stock Holding History

Armor Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,955	Closed	-$202K	–	174
2023 Q1	$202K	Hold	4,955	–	–	0.12%	107
2022 Q4	$254K	Hold	4,955	–	–	0.15%	103
2022 Q3	$217K	Buy	4,955 +1	+0%	+$49	0.15%	107
2022 Q2	$260K	Sell	4,954 -339	-6%	-$17.3K	0.17%	96
2022 Q1	$274K	Sell	5,293 -224	-4%	-$11.6K	0.16%	101
2021 Q4	$326K	Hold	5,517	–	–	0.18%	98
2021 Q3	$237K	Buy	5,517 +1	+0%	+$44	0.15%	108
2021 Q2	$216K	Hold	5,516	–	–	0.13%	116
2021 Q1	$200K	Sell	5,516 -1,049	-16%	-$37.2K	0.13%	114
2020 Q4	$242K	Buy	6,565 +657	+11%	+$24.1K	0.17%	96
2020 Q3	$206K	Buy	+5,908	New	+$207K	0.18%	90
2020 Q1	–	Sell	-5,760	Closed	-$214K	–	147
2019 Q4	$214K	Buy	+5,760	New	+$205K	0.17%	103
2019 Q3	–	Sell	-5,759	Closed	-$237K	–	150
2019 Q2	$237K	Sell	5,759 -1,107	-16%	-$44K	0.2%	87
2019 Q1	$277K	Buy	+6,866	New	+$275K	0.24%	81

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Armor Investment Advisors's PFE Position: Q2 2023 in Review

Armor Investment Advisors sold out of Pfizer (PFE) in Q2 2023, closing a stake of 4,955 shares — an estimated $202K sold.

Armor Investment Advisors first reported a position in PFE in Q1 2019 and held it in 14 quarters. The position peaked at $326K in Q4 2021. 3,042 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

Armor Investment Advisors reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
Armor Investment Advisors sold 4,955 Pfizer shares in Q2 2023, an estimated $202K.
Armor Investment Advisors first reported a position in Pfizer in Q1 2019 and held it in 14 quarters.
Armor Investment Advisors's Pfizer position peaked at $326K in Q4 2021.
3,042 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Armor Investment Advisors's 13F filing for Q2 2023, filed 19 Jul 2023.